Stick with statins for treating ACS

As a general rule it is overkill to prescribe intensive cholesterol-lowering treatment to patients with acute coronary syndrome and dyslipidemia, a Japanese researcher argues.

Presenting his study findings the ESC Congress in Rome last month, Professor Nobuhisa Hagiwara told delegates that for the most part, statin therapy alone is sufficient to improve cardiovascular outcomes in ACS patients.

The results show that a